Close Menu

NEW YORK (GenomeWeb) – Bellwether Bio, a liquid biopsy startup that recently spun out of the University of Washington, has raised almost $2.8 million in seed financing.

The company, cofounded by UW professor Jay Shendure and Matthew Snyder, a former graduate student in Shendure's lab, aims to commercialize technology based on determining fragmentation patterns in circulating cell-free DNA. Snyder is chief technology officer at Bellwether Bio, while Shendure, a professor in the Department of Genome Sciences, will serve as head of the company's scientific advisory board.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.